Answers are grounded in this paper and cite their sources.
Case-control study reveals no age-adjusted differences in serum complement C3, C3a, or C4 levels in cataract patients with pseudoexfoliation, indicating no major systemic complement pathway role.
Abstract Backgrounds: We aimed to compare serum complement C3, C3a, and C4 levels between cataract patients with and without pseudoexfoliation syndrome, and to compare these groups with the control group. Methods: There were three different groups in the study. The total of 150 patients, 50 in each group, were included. Group 1 consisted of cataract patients with pseudoexfoliation, Group 2 consisted of cataract patients without pseudoexfoliation, and Group 3 consisted of healthy individuals. After centrifugation of the blood samples, the serum portion was stored at –80°C until the analysis. Complement C3, C3a, and C4 levels were evaluated in these three groups using commercially available sandwich ELISA kits. Results: There was a statistically significant difference just between Group 1 and Group 2 regarding C4 values. However, after the age correction, this significance was disappeared. Conclusions: According to this study, there may not be a relationship between the complement pathway and the immune system in cataract patients with and without pseudoexfoliation syndrome.
No takes yet. Share an insight, caveat, or question.
Özışık et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: